Walleye Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$7.64K 4856
2025
Q4
$7.64K Sell
800
-1,900
-70% -$19.3K ﹤0.01% 4315
2025
Q3
$26.4K Buy
+2,700
New +$20.8K ﹤0.01% 4161
2025
Q1
Sell
-100
Closed -$1.39K 4953
2024
Q4
$1.39K Buy
+100
New +$1.58K ﹤0.01% 4689
2024
Q3
Sell
-8,300
Closed -$171K 5751
2024
Q2
$171K Buy
8,300
+3,900
+89% +$84.4K ﹤0.01% 4415
2024
Q1
$109K Buy
+4,400
New +$131K ﹤0.01% 4349
2023
Q4
Sell
-700
Closed -$33.8K 5390
2023
Q3
$33.8K Buy
700
+400
+133% +$23.8K ﹤0.01% 4285
2023
Q2
$20.5K Buy
+300
New +$19.4K ﹤0.01% 3796

Other funds holding PRTA

Walleye Capital's PRTA Position: Q2 2026 in Review

Walleye Capital sold out of Prothena Corp (PRTA) in Q2 2026, closing a stake of 277,168 shares — an estimated $2.69M sold.

Walleye Capital first reported a position in PRTA in Q1 2019 and held it in 10 quarters. The position peaked at $3.8M in Q2 2023. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Walleye Capital reported no remaining Prothena Corp position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 277,168 Prothena Corp shares in Q2 2026, an estimated $2.69M.
  • Walleye Capital first reported a position in Prothena Corp in Q1 2019 and held it in 10 quarters.
  • Walleye Capital's Prothena Corp position peaked at $3.8M in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.